T1	Participants 447 543	254 patients with colon cancer were randomly assigned postoperative ASI or no adjuvant treatment
T2	Participants 1100 1159	40 recurrences in the control group and 25 in the ASI group
T3	Participants 1258 1413	ASI was seen in patients with stage II disease, with a significantly longer recurrence-free period (p=0.011) and 61% (18-81) risk reduction for recurrences
